How much heparin do we really need to go on pump? A rethink of current practices

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Pharmacology

Background:

• Patients undergoing myocardial revascularisation with extracorporeal circulation require heparin anticoagulation.
• Optimizing heparin dosage is crucial for balancing anticoagulation efficacy and minimizing bleeding complications.

Purpose of the Study:

• To evaluate the impact of reduced heparin dosages on achieving target activated clotting time (ACT).
• To assess the effect of modified heparin regimens on postoperative blood loss in cardiac surgery patients.

Main Methods:

• A prospective randomized trial involving 195 patients undergoing isolated primary coronary artery bypass grafting (CABG).
• Patients were assigned to four groups receiving initial heparin doses of 100, 200, 250, or 300 iu/kg.
• Target ACT of 480 seconds was monitored, with incremental heparin added as needed before cardiopulmonary bypass.

Main Results:

• Higher initial heparin doses correlated with increased achievement of target ACT.
• Postoperative blood loss was directly proportional to the preoperative heparin dose administered.
• A starting dose of 200 iu/kg with one 50 iu/kg increment achieved target ACT in 81.5% of patients, with Group B (200 iu/kg) being closest to the target ACT.

Conclusions:

• Lowering initial heparin dosage in cardiac surgery reduces postoperative blood loss.
• A regimen of 200 iu/kg initial heparin with a potential 50 iu/kg increment effectively achieves target ACT in most patients.
• This optimized heparin strategy offers the dual benefit of adequate anticoagulation and decreased surgical bleeding.